Curis | CRIS - SCHULD





SCHULD Veränderung Datum
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Amgen USD 54.6B 17M 2025-12
AstraZeneca USD 33.92B 4.3B 2026-03
Bayer EUR 36.45B 2.93B 2025-12
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
CSL USD 11.96B 219M 2024-12
Curis USD 0 0 2022-06
Eli Lilly USD 42.5B 3.6M 2025-12
Exelixis USD 169.54M 3.5M 2026-03
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Incyte USD 39.43M 982K 2026-03
Merck USD 49.34B 7.97B 2025-12
Novartis USD 47B 11.62B 2026-03
Pfizer USD 63.73B 231M 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 20.33B 1.43B 2025-12
Takeda JPY 4.85T 208B 2025-12
TG Therapeutics USD 253.71M 8.37M 2025-12
Verastem USD 66.79M 26.7M 2024-09
Xoma USD 120.79M 3.27M 2024-06